Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it will not be funded by the French social security system. Danish ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Hoping your company will begin paying for anti-obesity medications ... diabetes had started taking GLP-1 drugs. DSV, a global transportation company based in New Jersey, had not put any ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

Discover ADM's new solutions platform for GLP-1 consumers. With over 25 market-ready concepts, it assists those on ...

Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...